TOPLINE:Cardiac dysfunction associated with vascular endothelial growth factor (VEGF) inhibitors in cancer therapy was common and tended to occur early....
Treatment
A commonly prescribed diabetes medication could significantly enhance long-term recovery prospects for cancer patients by reducing their risk of heart...
In the intersection of cardiology and oncology, the risks of cardiotoxicity from cancer treatments remain a pressing issue. Han Zhu,...
Introduction Lung cancer mortality has been declining over the past two decades driven in part by advances in systemic therapies...
Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248–64.Article CAS PubMed Central ...
This story first appeared in Healthy You - January 2025, The Gazette’s quarterly health publication. In 2022, there were 18.1...
